Moore DF - Search Results

1

Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke.

Dubuc V, Moore DF, Gioia LC, Saposnik G, Selchen D, Lanthier S. Dubuc V, et al. Among authors: moore df. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1288-92. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.005. Epub 2012 Nov 17. J Stroke Cerebrovasc Dis. 2013. PMID: 23168217

2

Enhanced endothelium-dependent vasodilation in Fabry disease.

Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, Panza JA, Schiffmann R. Altarescu G, et al. Among authors: moore df. Stroke. 2001 Jul;32(7):1559-62. doi: 10.1161/01.str.32.7.1559. Stroke. 2001. PMID: 11441201 Free PMC article.

3

Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.

Moore DF, Altarescu G, Ling GS, Jeffries N, Frei KP, Weibel T, Charria-Ortiz G, Ferri R, Arai AE, Brady RO, Schiffmann R. Moore DF, et al. Stroke. 2002 Feb;33(2):525-31. doi: 10.1161/hs0202.102601. Stroke. 2002. PMID: 11823664 Clinical Trial.

4

Pediatric Fabry disease.

Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GJ, Rosing DR, Robinson C, Schaefer E, Gal A, Dambrosia JM, Garman SC, Brady RO, Schiffmann R. Ries M, et al. Among authors: moore df. Pediatrics. 2005 Mar;115(3):e344-55. doi: 10.1542/peds.2004-1678. Epub 2005 Feb 15. Pediatrics. 2005. PMID: 15713906

5

Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.

Moore DF, Gelderman MP, Ferreira PA, Fuhrmann SR, Yi H, Elkahloun A, Lix LM, Brady RO, Schiffmann R, Goldin E. Moore DF, et al. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8065-70. doi: 10.1073/pnas.0701991104. Epub 2007 Apr 30. Proc Natl Acad Sci U S A. 2007. PMID: 17470787 Free PMC article.

6

Fabry's disease: a prospective multicenter cohort study in young adults with cryptogenic stroke.

Saposnik G, Lanthier S, Mamdani M, Thorpe KE, Melo M, Pope K, Selchen D, Moore DF; Canadian Stroke Consortium; Stroke Outcome Research Canada (SORCan) Working Group. Saposnik G, et al. Among authors: moore df. Int J Stroke. 2012 Apr;7(3):265-73. doi: 10.1111/j.1747-4949.2011.00734.x. Epub 2012 Jan 20. Int J Stroke. 2012. PMID: 22264232

7

Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events.

Lanthier S, Saposnik G, Lebovic G, Pope K, Selchen D, Moore DF; Canadian Fabry Stroke Screening Initiative Study Group. Lanthier S, et al. Among authors: moore df. Stroke. 2017 Jul;48(7):1766-1772. doi: 10.1161/STROKEAHA.116.016083. Epub 2017 Jun 8. Stroke. 2017. PMID: 28596458

8

Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO. Schiffmann R, et al. Among authors: moore df. JAMA. 2001 Jun 6;285(21):2743-9. doi: 10.1001/jama.285.21.2743. JAMA. 2001. PMID: 11386930 Clinical Trial.

9

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.

Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, Pease-Fye M, Ferri R, Brady RO, Herscovitch P, Schiffmann R. Moore DF, et al. Circulation. 2001 Sep 25;104(13):1506-12. doi: 10.1161/hc3801.096352. Circulation. 2001. PMID: 11571244 Clinical Trial.

10

Enzyme replacement therapy in Fabry disease.

Brady RO, Murray GJ, Moore DF, Schiffmann R. Brady RO, et al. Among authors: moore df. J Inherit Metab Dis. 2001;24 Suppl 2:18-24; discussion 11-2. doi: 10.1023/a:1012451320105. J Inherit Metab Dis. 2001. PMID: 11758675 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters